loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Pharmaceutical Excipients offered by Nomisma Healthcare? Find Poly DL Lactic Acid / PDLLA or Poly DL Lactide co Glycolide / PDLLGA or Poly L Lactic Acid / PLLA or Poly L lactic acid co glycolic acid / PLLGA or Polyglycolic Acid Excipient / PGA to address your drug delivery challenges on PharmaCompass.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    View Presentation

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Nomisma Healthcare

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Injectable / Parenteral

    02 5Tablet

    filter clear-filterReset all filters

    PharmaCompass

    01

    Brand Name : PDLLA

    PDLLA

    arrow
    The Pharmacy Technology
    Not Confirmed

    Brand Name : PDLLA

    India
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    Nomisma Healthcare

    Application : Controlled & Modified Release, Parenteral

    Excipient Details : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Ingredient(s) : Poly DL Lactide

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly DL Lactide

    Dosage Form : Injectable / Parenteral, Tablet

    Category : Controlled & Modified Release, Parenteral

    Brand : PDLLA

    Applications : PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    02

    Brand Name : PLGA

    PLGA

    arrow
    The Pharmacy Technology
    Not Confirmed

    Brand Name : PLGA

    India
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    Nomisma Healthcare

    Application : Controlled & Modified Release, Parenteral

    Excipient Details : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

    Ingredient(s) : Poly DL Lactide co Glycolide

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly DL Lactide co Glycolide

    Dosage Form : Injectable / Parenteral, Tablet

    Category : Controlled & Modified Release, Parenteral

    Brand : PLGA

    Applications : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    03

    Brand Name : PLGA-PEG

    PLGA-PEG

    arrow
    The Pharmacy Technology
    Not Confirmed

    Brand Name : PLGA-PEG

    India
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    Nomisma Healthcare

    Application : Controlled & Modified Release

    Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

    Dosage Form : Tablet

    Category : Controlled & Modified Release

    Brand : PLGA-PEG

    Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    04

    Brand Name : PLLA

    PLLA

    arrow
    The Pharmacy Technology
    Not Confirmed

    Brand Name : PLLA

    India
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    Nomisma Healthcare

    Application : Controlled & Modified Release, Parenteral

    Excipient Details : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Ingredient(s) : Poly L Lactide

    Dosage Form : Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly L Lactide

    Dosage Form : Injectable / Parenteral, Tablet

    Category : Controlled & Modified Release, Parenteral

    Brand : PLLA

    Applications : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    05

    Brand Name : PLLA-PEG

    PLLA-PEG

    arrow
    The Pharmacy Technology
    Not Confirmed